Analysis of nursing effect of liraglutide combined with acarbose in the treatment of type 2 diabetes
利拉鲁肽联合阿卡波糖治疗2型糖尿病的护理效果分析

摘要

目的 研究分析利拉鲁肽联合阿卡波糖治疗2型糖尿病的效果，同时对患者进行优质护理，主要观察患者的疗效和胰岛功能。方法 随机抽取2020年5月-2021年5月期间我院治疗的80例2型糖尿病患者作为研究对象，使用抽签法进行分组，分别为对照组40例、实验组40例，两组患者均采用阿卡波糖联合利拉鲁肽治疗。对照组应用常规护理，实验组应用优质护理，比较实验组、对照组患者的血糖指标和治疗效果情况。结果 实验组2型糖尿病患者的血糖指标评分低于对照组，数据对比存在差异（P<0.05）；实验组患者的治疗效果高于对照组，数据有统计学意义（P<0.05）。实验组患者治疗后的不良反应发生率低于对照组，差异存在可比性(P<0.05)。结论 患者接受利拉鲁肽联合阿卡波糖治疗后对患者实施优质护理，能够促进2型糖尿病患者的机体功能恢复，能够降低患者的血糖指标，值得临床广泛推广应用。

Abstract

Objective: To study and analyze the effect of liraglutide combined with acarbose in the treatment of type 2 diabetes, and to provide high-quality nursing care for patients, mainly to observe the curative effect and islet function of patients.
Methods: 80 patients with type 2 diabetes treated in our hospital from May 2020 to may 2021 were randomly selected as the research objects. They were divided into control group (40 cases) and experimental group (40 cases) by lot. Both groups were treated with acarbose and liraglutide. Routine nursing was used in the control group and high-quality nursing was used in the experimental group. The blood glucose indexes and treatment effects of patients in the experimental group and the control group were compared.
Results: the score of blood glucose index in the experimental group was lower than that in the control group (p<0.05); The therapeutic effect of the experimental group was higher than that of the control group, and the data were statistically significant (P < 0.05). The incidence of adverse reactions in the experimental group was lower than that in the control group (P < 0.05).
Conclusion  : after receiving liraglutide combined with acarbose, high-quality nursing care for patients can promote the recovery of body function in patients with type 2 diabetes and reduce the blood glucose index of patients, which is worthy of wide clinical application.